A popular drug for psoriatic arthritis pain may soon cost a lot less.
For the first time, Celebrex (celecoxib) will become available in generic versions, following approval last week from the Food and Drug Administration (FDA). The FDA approved 50 milligram (mg), 100 mg, 200 mg and 400 mg capsules of the drug.
Celebrex is a nonsteroidal anti-inflammatory drug (NSAID) used to treat rheumatoid arthritis and osteoarthritis. It is sometimes prescribed to help relieve the pain of psoriatic arthritis. Celebrex targets COX-2, which is an enzyme that causes inflammation and pain. Common side effects include stomachache, diarrhea and indigestion.
According to a court decision, the generic will hit the market in December.
Driving Discovery, Creating Community
This year, we’re celebrating 50 years of driving efforts to cure psoriatic disease and improve the lives of those affected. See how far we’ve come with this timeline of NPF’s history. But there’s still plenty to do, and we can’t do it without you! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funding to promote research into better treatments and a cure by joining Team NPF, where you can walk, run, cycle, play bingo or even create your own DIY event. Contact our Patient Navigation Center for free, personalized support for living a healthier life with psoriatic disease. And keep the National Psoriasis Foundation going strong by making a donation today! Together, we will find a cure.